Literature DB >> 7612590

Our 10-year experience with embolized Wilms' tumor.

B Zupancić1, I Bradić, S Batinica, B Radanović, S Simunić, V Zupancić, L Popović, D Belina.   

Abstract

In the Department of Pediatric Surgery, Clinical Hospital Center Rebro in Zagreb, during the last 10 years a new method of invasive diagnostic and at the same time therapeutic procedure for the treatment of Wilms' tumor has been introduced. The treatment is preoperative Percutaneous Transcatheter Intraarterial Embolization (PTIE) of the renal artery. The aim of this procedure is to reduce vascularization, to decrease the mass of kidney affected by the tumor, to separate it from the surrounding tissue, to decrease intraoperative spillage of malignant cells into the blood stream and their metastasizing. As a result nephrectomy is easier to perform. It has been confirmed that it is best to perform nephrectomy 48 hours after embolization. The authors present their own experience with 33 patients, ranging from 1 to 16 years of age.

Entities:  

Mesh:

Year:  1995        PMID: 7612590     DOI: 10.1055/s-2008-1066174

Source DB:  PubMed          Journal:  Eur J Pediatr Surg        ISSN: 0939-7248            Impact factor:   2.191


  3 in total

1.  Emergent embolisation to control severe haematuria in Wilms' tumour.

Authors:  N P Smith; E C Jesudason; H P McDowell; P Rowlands; M Ashworth; P D Losty
Journal:  Pediatr Surg Int       Date:  2005-03-04       Impact factor: 1.827

2.  A report of renal artery embolization for hematuria facilitating neoadjuvant chemotherapy in an unresectable malignant renal rhabdoid tumor.

Authors:  Ruchika Sharma; Brenda J Kitchen; Rajen Mody; Aghiad Chamdin; Steven Bruch; Rama Jasty
Journal:  Pediatr Surg Int       Date:  2013-01-24       Impact factor: 1.827

3.  A gel-forming poly-L: -guluronic acid produced from no guluronate-rich marine algae using new hydrolysis method: test for endovascular embolization.

Authors:  Hyun Mee Lee; Yeon-Hee Yoon; Woo-Back Lee; Jong-Ki Kim
Journal:  J Mater Sci Mater Med       Date:  2009-04-28       Impact factor: 3.896

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.